Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
STING antagonist
NSAID; COX-1/2 and lactate dehydrogenase inhibi...
Endogenous prostaglandin, vasodilator.
Synthesis impurity
TGF-β1 inhibitor.
Light-emitting luciferin analog found in aquati...
β-adrenergic agonist.
Cysteine conjugate of benzyl isothiocyanate (BI...
Electron carrier used to study dehydrogenase el...
Caffeic acid derivative.
V2 antagonist.
Calcium channel blocker.
pan-PI3K inhibitor
Anthracycline, DNA intercalator; topoisomerase ...
CDK inhibitor, L-type Ca2+ channel blocker.
Benzisoxazole phenylethanone; D2 and 5-HT2A ant...
Phallotoxin found in Amanita phalloides; microt...
Cap-dependent endonuclease inhibitor
Endogenous peptide hormone, involved in intesti...
Inhibitor of T-lymphokine-activated killer cell...